Literature DB >> 24891046

Brain MRI abnormalities and spectrum of neurological and clinical findings in three patients with proximal 16p11.2 microduplication.

Isabel Filges1, Steven Sparagana, Michael Sargent, Kathryn Selby, Kamilla Schlade-Bartusiak, Gregg T Lueder, Amy Robichaux-Viehoever, Bradley L Schlaggar, Joshua S Shimony, Marwan Shinawi.   

Abstract

The phenotype of recurrent ∼600 kb microdeletion and microduplication on proximal 16p11.2 is characterized by a spectrum of neurodevelopmental impairments including developmental delay and intellectual disability, epilepsy, autism and psychiatric disorders which are all subject to incomplete penetrance and variable expressivity. A variety of brain MRI abnormalities were reported in patients with 16p11.2 rearrangements, but no systematic correlation has been studied among patients with similar brain anomalies, their neurodevelopmental and clinical phenotypes. We present three patients with the proximal 16p11.2 microduplication exhibiting significant developmental delay, anxiety disorder and other variable clinical features. Our patients have abnormal brain MRI findings of cerebral T2 hyperintense foci (3/3) and ventriculomegaly (2/3). The neuroradiological or neurological findings in two cases prompted an extensive diagnostic work-up. One patient has exhibited neurological regression and progressive vision impairment and was diagnosed with juvenile neuronal ceroid-lipofuscinosis. We compare the clinical course and phenotype of these patients in regard to the clinical significance of the cerebral lesions and the need for MRI surveillance. We conclude that in all three patients the lesions were not progressive, did not show any sign of malignant transformation and could not be correlated to specific clinical features. We discuss potential etiologic mechanisms that may include overexpression of genes within the duplicated region involved in control of cell proliferation and complex molecular mechanisms such as the MAPK/ERK pathway. Systematic studies in larger cohorts are needed to confirm our observation and to establish the prevalence and clinical significance of these neuroanatomical abnormalities in patients with 16p11.2 duplications.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  16p11.2; MRI; T2-hyperintensity; microduplication; neurological

Mesh:

Year:  2014        PMID: 24891046     DOI: 10.1002/ajmg.a.36605

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  A diagnostic confidence scheme for CLN3 disease.

Authors:  Margaux C Masten; Camille Corre; Alex R Paciorkowski; Amy Vierhile; Heather R Adams; Jennifer Vermilion; Grace A Zimmerman; Erika F Augustine; Jonathan W Mink
Journal:  J Inherit Metab Dis       Date:  2021-09-07       Impact factor: 4.750

2.  Exome sequencing identifies pathogenic variants of VPS13B in a patient with familial 16p11.2 duplication.

Authors:  Jila Dastan; Chieko Chijiwa; Flamingo Tang; Sally Martell; Ying Qiao; Evica Rajcan-Separovic; M E Suzanne Lewis
Journal:  BMC Med Genet       Date:  2016-11-10       Impact factor: 2.103

3.  The Noonan Syndrome-linked Raf1L613V mutation drives increased glial number in the mouse cortex and enhanced learning.

Authors:  Michael C Holter; Lauren T Hewitt; Stephanie V Koebele; Jessica M Judd; Lei Xing; Heather A Bimonte-Nelson; Cheryl D Conrad; Toshiyuki Araki; Benjamin G Neel; William D Snider; Jason M Newbern
Journal:  PLoS Genet       Date:  2019-04-24       Impact factor: 5.917

4.  Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling.

Authors:  Melanie Richter; Nadeem Murtaza; Stephen W Scherer; Karun K Singh; Froylan Calderon de Anda; Robin Scharrenberg; Sean H White; Ole Johanns; Susan Walker; Ryan K C Yuen; Birgit Schwanke; Bianca Bedürftig; Melad Henis; Sarah Scharf; Vanessa Kraus; Ronja Dörk; Jakob Hellmann; Zsuzsa Lindenmaier; Jacob Ellegood; Henrike Hartung; Vickie Kwan; Jan Sedlacik; Jens Fiehler; Michaela Schweizer; Jason P Lerch; Ileana L Hanganu-Opatz; Fabio Morellini
Journal:  Mol Psychiatry       Date:  2018-02-21       Impact factor: 15.992

5.  Reversal of synaptic and behavioral deficits in a 16p11.2 duplication mouse model via restoration of the GABA synapse regulator Npas4.

Authors:  Benjamin Rein; Tao Tan; Fengwei Yang; Wei Wang; Jamal Williams; Freddy Zhang; Alea Mills; Zhen Yan
Journal:  Mol Psychiatry       Date:  2020-02-25       Impact factor: 13.437

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.